Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Visaris Vision® (Vision C, Vision U. Vision V, Vision X)

K-Number: K160620 · 2016-03-30

Decision Date2016-03-30
Product CodeKPR
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is the device name listed in this FDA 510(k) record. The listed applicant is Visaris D.O.O. Belgrade. It received FDA 510(k) clearance on 2016-03-30 under 510(k) number K160620. The device is classified under product code KPR. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is a medical device that received FDA 510(k) clearance on 2016-03-30. The listed applicant is Visaris D.O.O. Belgrade. The 510(k) number is K160620.

When did Visaris Vision® (Vision C, Vision U. Vision V, Vision X) receive FDA 510(k) clearance?

Visaris Vision® (Vision C, Vision U. Vision V, Vision X) received FDA 510(k) clearance on 2016-03-30, under 510(k) number K160620.

Who is the listed applicant for Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

The FDA 510(k) record lists Visaris D.O.O. Belgrade as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Visaris Vision® (Vision C, Vision U. Vision V, Vision X)?

The FDA product code for Visaris Vision® (Vision C, Vision U. Vision V, Vision X) is KPR.

Related Devices (Code: KPR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.